Cargando…

Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats

Cardiovascular (CV) disease is the main cause of death in nonalcoholic fatty liver disease (NAFLD), a clinical condition without any approved pharmacological therapy. Thus, we investigated the effects of ornithine aspartate (LOLA) and/or Vitamin E (VitE) on CV parameters in a steatohepatitis experim...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Freitas, Laura Bainy Rodrigues, Longo, Larisse, Filippi-Chiela, Eduardo, de Souza, Valessa Emanoele Gabriel, Behrens, Luiza, Pereira, Matheus Henrique Mariano, Leonhard, Luiza Cecília, Zanettini, Giulianna, Pinzon, Carlos Eduardo, Luchese, Eduardo, Lima, Guilherme Jorge Semmelmann Pereira, Cerski, Carlos Thadeu, Uribe-Cruz, Carolina, Álvares-da-Silva, Mário Reis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775092/ https://www.ncbi.nlm.nih.gov/pubmed/36551202 http://dx.doi.org/10.3390/biom12121773

Ejemplares similares

Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
por: Longo, Larisse, et al.
Publicado: (2021)

Protocol to segment and characterize the morphometry of individual cross-sectioned striated muscle fibers from adult murine models
por: Bartikoski, Bárbara Jonson, et al.
Publicado: (2022)

Transcranial direct current stimulation (tDCS) has beneficial effects on liver lipid accumulation and hepatic inflammatory parameters in obese rats
por: Longo, Larisse, et al.
Publicado: (2021)

Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats
por: Longo, Larisse, et al.
Publicado: (2020)

Laterality influence on gene expression of DNA damage repair in colorectal cancer
por: Oliveira-Silveira, Juliano, et al.
Publicado: (2023)

Signet-ring cell hilar cholangiocarcinoma: case report
por: CHEDID, Marcio F., et al.
Publicado: (2015)

Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
por: Kircheis, Gerald, et al.
Publicado: (2019)

Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population
por: de Freitas, Laura Bainy Rodrigues, et al.
Publicado: (2019)

Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model
por: Vargas, José Eduardo, et al.
Publicado: (2020)

Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats
por: Najmi, Abul K., et al.
Publicado: (2010)

Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs
por: Ahn, Jin-Ok, et al.
Publicado: (2016)

Induction of selective liver hypothermia prevents significant ischemia/reperfusion injury in Wistar rats after 24 hours
por: Grezzana, Tomaz de Jesus Maria, et al.
Publicado: (2020)

Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2022)

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations
por: Pichon, Camille, et al.
Publicado: (2022)

Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
por: Filippi-Chiela, Eduardo C, et al.
Publicado: (2013)

Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells
por: Filippi-Chiela, Eduardo C., et al.
Publicado: (2011)

L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle
por: Butterworth, Roger F.
Publicado: (2019)

Chloroform induction of ornithine decarboxylase activity in rats.
por: Savage, R E, et al.
Publicado: (1982)

Effect of Rifaximin, Probiotics, and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy: A Randomized Controlled Trial
por: Sharma, Kapil, et al.
Publicado: (2014)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
por: Butterworth, Roger F., et al.
Publicado: (2019)

L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson’s Disease Models
por: Sisalli, Maria Josè, et al.
Publicado: (2022)

Single-cell analysis challenges the connection between autophagy and senescence induced by DNA damage
por: Filippi-Chiela, Eduardo Cremonese, et al.
Publicado: (2015)

The paradox of autophagy in Tuberous Sclerosis Complex
por: Reis, Larissa Brussa, et al.
Publicado: (2021)

Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones
por: Mielcke, Tânia R., et al.
Publicado: (2017)

Bipolar Membrane Electrodialysis for Direct Conversion of L-Ornithine Monohydrochloride to L-Ornithine
por: He, Jinfeng, et al.
Publicado: (2023)

Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis
por: Butterworth, Roger F.
Publicado: (2019)

Microvessel Density (Chalkley Method) in a Series of 79 Gastrointestinal Stromal Tumors
por: Waengertner, Luiz Eduardo, et al.
Publicado: (2011)

Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities
por: Filippi-Chiela, Eduardo C., et al.
Publicado: (2012)

Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014)

Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma
por: Chedid, Marcio F., et al.
Publicado: (2016)

Neonatal Liver Failure and Congenital Cirrhosis due to Gestational Alloimmune Liver Disease: A Case Report and Literature Review
por: Roos Mariano da Rocha, Carolina, et al.
Publicado: (2017)

Liver involvement in patients with Gaucher disease types I and III
por: Starosta, Rodrigo Tzovenos, et al.
Publicado: (2020)

A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy
por: Grover, Vijay P. B., et al.
Publicado: (2016)

Altitude and Quality of Life of Older People in Colombia: A Multilevel Study
por: Pinzón-Rondón, Angela Maria, et al.
Publicado: (2022)

Ornithine Lipids in Burkholderia spp. Pathogenicity
por: Córdoba-Castro, Luz América, et al.
Publicado: (2021)

Diseño e implementación de un depurador concurrente para sistemas de multiprocesamiento
por: Uribe Blanco, Carlos Eduardo
Publicado: (1992)

Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency
por: Li, Sitao, et al.
Publicado: (2018)

Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells
por: Solari, José Ignácio Gonzalez, et al.
Publicado: (2020)

Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats
por: Moreira, Andrea J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4amoqn0nkn6o73r09jmibtmgor